Literature DB >> 17501765

Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.

V A Arankalle1, K S Lole, T M Deshmukh, L P Chobe, S S Gandhe.   

Abstract

Open reading frame 2 proteins (ORF2) from swine (genotype 4, S-ORF2) and human (genotype 1, H-ORF2) hepatitis E virus (HEV) having 91.4% identity at amino acid level were expressed using baculovirus expression system. Comparison of ELISAs based on the two proteins yielded identical results when sequential serum samples from monkeys and pigs experimentally infected with genotypes 1 and 4 HEV, respectively, were tested. Samples from patients (n = 258) suffering from non-A, non-B hepatitis during outbreaks of the disease and 180 sera from apparently healthy children were screened by H-ORF2-, S-ORF2-based ELISAs and Genelabs ELISA, a widely used commercial test for HEV diagnosis. Specificity of all three tests in detecting IgM and IgG antibodies in healthy children was comparable. Excellent correlation was noted in detecting both IgM (98.7% concordance) and IgG (97.7% concordance) anti-HEV antibodies when H-ORF2 and S-ORF2 ELISAs were compared. When compared with Genelabs ELISA, both H-ORF2 and S-ORF2 ELISAs identified 34 and 18 additional positives, respectively, in IgM and IgG anti-HEV tests showing comparatively less sensitivity of the commercial assay. The concordance of Genelabs ELISA in IgM detection was 86.4% and 85.6%, respectively, with H-ORF2 and S-ORF2 ELISAs. The concordance between Genelabs ELISA and H-ORF2 decreased further to 73.6% when 129 human samples from recent HEV epidemics (2002-2004) were tested for IgM. Similar results were obtained when sequential samples from 11 hepatitis E patients were examined. Screening of serum samples from 137 sporadic non-A, non-B hepatitis cases further confirmed the superiority of the H-ORF2 and S-ORF2 ELISAs. All 36/137 HEV-RNA-positive samples from sporadic cases belonged to genotype 1 confirming absence/rarity of type 4 human infections. H-ORF2 and S-ORF2 antigens were swappable in ELISAs for detecting both genotypes 1 and 4 HEV infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17501765     DOI: 10.1111/j.1365-2893.2006.00801.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  25 in total

1.  Detection of negative-sense RNA in packaged hepatitis E virions by use of an improved strand-specific reverse transcription-PCR method.

Authors:  Subhashis N Chatterjee; Pradip B Devhare; Kavita S Lole
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 2.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

3.  Peripheral T regulatory cells and cytokines in hepatitis E infection.

Authors:  A S Tripathy; R Das; S B Rathod; Y K Gurav; V A Arankalle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-20       Impact factor: 3.267

4.  Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States.

Authors:  Chen Dong; Jihong Meng; Xing Dai; Jiu-Hong Liang; Alicia R Feagins; Xiang-Jin Meng; Natalia M Belfiore; Carol Bradford; Joseph L Corn; Carolyn Cray; Gregory E Glass; Melvin L Gordon; Richard A Hesse; Donald L Montgomery; William L Nicholson; Anthony A Pilny; Sheela Ramamoorthy; Douglas D Shaver; Jan Drobeniuc; Michael A Purdy; Howard A Fields; Saleem Kamili; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

5.  Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus.

Authors:  Neha Gupta; Aditya N Sarangi; Sunil Dadhich; V K Dixit; Kamal Chetri; Amit Goel; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2018-02-05

6.  An outbreak of hepatitis E tracked to a spring in the foothills of the Himalayas, India, 2005.

Authors:  Harish Chandra Singh Martolia; Yvan Hutin; Vidya Ramachandran; Ponniah Manickam; Manoj Murhekar; Mohan Gupte
Journal:  Indian J Gastroenterol       Date:  2009-11-12

7.  A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus.

Authors:  Jiu-Hong Liang; Xing Dai; Chen Dong; Ji-Hong Meng
Journal:  Int J Mol Sci       Date:  2010-08-12       Impact factor: 5.923

8.  Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.

Authors:  Andi Krumbholz; Sebastian Joel; Paul Dremsek; Anne Neubert; Reimar Johne; Ralf Dürrwald; Mario Walther; Thomas H Müller; Detlef Kühnel; Jeannette Lange; Peter Wutzler; Andreas Sauerbrei; Rainer G Ulrich; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2014-04-18       Impact factor: 3.402

9.  Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.

Authors:  Nereida Jiménez de Oya; Inmaculada Galindo; Olivia Gironés; Erwin Duizer; José M Escribano; Juan-Carlos Saiz
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

10.  Increased expressions of NKp44, NKp46 on NK/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection.

Authors:  Rumki Das; Anuradha Tripathy
Journal:  Med Microbiol Immunol       Date:  2014-05-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.